Cisen Pharmaceutical Co., Ltd. (SHA:603367)
China
· Delayed Price · Currency is CNY 14.26
-0.02 (-0.14%)
Apr 3, 2025, 2:45 PM CST
Cisen Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Cash & Equivalents | 606.84 | 983.39 | 997.95 | 938.98 | 661.42 | 386.29 | Upgrade
|
| Short-Term Investments | 133.3 | 154.11 | 236.27 | - | - | - | Upgrade
|
| Trading Asset Securities | 1,812 | 1,638 | 1,550 | 1,485 | 1,875 | 1,977 | Upgrade
|
| Cash & Short-Term Investments | 2,552 | 2,775 | 2,784 | 2,424 | 2,537 | 2,363 | Upgrade
|
| Cash Growth | -5.45% | -0.32% | 14.87% | -4.46% | 7.36% | 556.19% | Upgrade
|
| Accounts Receivable | 1,109 | 1,363 | 1,272 | 1,048 | 738.84 | 732.4 | Upgrade
|
| Other Receivables | 16.21 | 4.24 | 9.25 | 11.35 | 8.77 | 4.94 | Upgrade
|
| Receivables | 1,125 | 1,367 | 1,281 | 1,060 | 747.61 | 737.34 | Upgrade
|
| Inventory | 846.37 | 708.22 | 580.43 | 594.65 | 572.12 | 600.9 | Upgrade
|
| Other Current Assets | 281.61 | 119.41 | 99.63 | 66.45 | 93.84 | 81.34 | Upgrade
|
| Total Current Assets | 4,806 | 4,970 | 4,745 | 4,145 | 3,950 | 3,782 | Upgrade
|
| Property, Plant & Equipment | 1,616 | 1,390 | 1,489 | 1,591 | 1,637 | 1,344 | Upgrade
|
| Long-Term Investments | 5.96 | 602.27 | 265.08 | 308.01 | 246.59 | 52.99 | Upgrade
|
| Other Intangible Assets | 205.52 | 211.6 | 213.03 | 210.82 | 207.92 | 208.02 | Upgrade
|
| Long-Term Deferred Tax Assets | 77.08 | 79.83 | 86.72 | 81.65 | 63.12 | 65.59 | Upgrade
|
| Long-Term Deferred Charges | 0.36 | 1.91 | 3.86 | 2.05 | - | - | Upgrade
|
| Other Long-Term Assets | 765.98 | 81.94 | 12.87 | 25.54 | 61.09 | 80.61 | Upgrade
|
| Total Assets | 7,476 | 7,338 | 6,815 | 6,364 | 6,166 | 5,534 | Upgrade
|
| Accounts Payable | 595.16 | 468.01 | 459.71 | 434.97 | 502.13 | 390.6 | Upgrade
|
| Accrued Expenses | 92.18 | 319.77 | 259.48 | 214.52 | 219.74 | 203.52 | Upgrade
|
| Short-Term Debt | 46.06 | 34.8 | 57.79 | 130 | 330 | 100 | Upgrade
|
| Current Portion of Leases | 3.34 | 3.34 | 0.3 | 2.72 | - | - | Upgrade
|
| Current Income Taxes Payable | 26.89 | 34.67 | 5.61 | 1.18 | 8.24 | 3.34 | Upgrade
|
| Current Unearned Revenue | 96.58 | 100.16 | 118.78 | 70.05 | 70.53 | - | Upgrade
|
| Other Current Liabilities | 644.1 | 409.17 | 380.24 | 365.5 | 153.7 | 188.08 | Upgrade
|
| Total Current Liabilities | 1,504 | 1,370 | 1,282 | 1,219 | 1,284 | 885.54 | Upgrade
|
| Long-Term Debt | 28 | 128.5 | 100 | - | - | - | Upgrade
|
| Long-Term Leases | 2.36 | 4.03 | 0.51 | 10.91 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 55.02 | 56.25 | 65.36 | 74.43 | 75.02 | 71.67 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 16.31 | 12.68 | 11.46 | 3.87 | 4.4 | 2.77 | Upgrade
|
| Total Liabilities | 1,606 | 1,571 | 1,459 | 1,308 | 1,364 | 959.97 | Upgrade
|
| Common Stock | 452.76 | 452.78 | 453.31 | 453.33 | 453.35 | 453.35 | Upgrade
|
| Additional Paid-In Capital | 1,928 | 1,919 | 1,913 | 1,863 | 1,844 | 1,882 | Upgrade
|
| Retained Earnings | 3,459 | 3,358 | 2,989 | 2,774 | 2,556 | 2,238 | Upgrade
|
| Treasury Stock | -0.08 | -0.08 | -19.77 | -32.74 | -50.49 | - | Upgrade
|
| Comprehensive Income & Other | -3.35 | -2.69 | -2.93 | -3.07 | -2.12 | -0.07 | Upgrade
|
| Total Common Equity | 5,837 | 5,727 | 5,332 | 5,055 | 4,801 | 4,573 | Upgrade
|
| Minority Interest | 33.43 | 39.1 | 23.64 | 0.75 | 1 | 1.22 | Upgrade
|
| Shareholders' Equity | 5,870 | 5,766 | 5,356 | 5,056 | 4,802 | 4,574 | Upgrade
|
| Total Liabilities & Equity | 7,476 | 7,338 | 6,815 | 6,364 | 6,166 | 5,534 | Upgrade
|
| Total Debt | 79.76 | 170.67 | 158.61 | 143.63 | 330 | 100 | Upgrade
|
| Net Cash (Debt) | 2,473 | 2,604 | 2,625 | 2,280 | 2,207 | 2,263 | Upgrade
|
| Net Cash Growth | -2.96% | -0.79% | 15.15% | 3.32% | -2.48% | 528.42% | Upgrade
|
| Net Cash Per Share | 5.47 | 5.75 | 5.78 | 5.05 | 4.88 | 5.01 | Upgrade
|
| Filing Date Shares Outstanding | 452.75 | 452.76 | 451.36 | 449.83 | 447.8 | 453.35 | Upgrade
|
| Total Common Shares Outstanding | 452.75 | 452.76 | 451.34 | 449.83 | 447.8 | 453.35 | Upgrade
|
| Working Capital | 3,302 | 3,600 | 3,463 | 2,926 | 2,666 | 2,897 | Upgrade
|
| Book Value Per Share | 12.89 | 12.65 | 11.81 | 11.24 | 10.72 | 10.09 | Upgrade
|
| Tangible Book Value | 5,632 | 5,516 | 5,119 | 4,844 | 4,593 | 4,365 | Upgrade
|
| Tangible Book Value Per Share | 12.44 | 12.18 | 11.34 | 10.77 | 10.26 | 9.63 | Upgrade
|
| Buildings | - | 1,275 | 1,188 | 1,191 | 975.57 | 969.84 | Upgrade
|
| Machinery | - | 2,093 | 1,903 | 1,797 | 1,494 | 1,398 | Upgrade
|
| Construction In Progress | - | 66.68 | 207.17 | 199.71 | 582.04 | 309.37 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.